Skip to content
The Longevity Archive
Elecoglipron in all countries

Legal status · Australia

Is Elecoglipron legal in Australia?

InvestigationalMetabolicEvidence: Moderate

No. Elecoglipron is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Elecoglipron in Australia at a glance

ClassificationInvestigational, not registered
TGA approval statusNot approved by TGA; investigational
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Elecoglipron profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    Elecoglipron is being studied in registered clinical trials but has not received TGA marketing approval in Australia.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Elecoglipron is

AstraZeneca's once-daily oral GLP-1 pill, 10.5% weight loss at 26 weeks in Phase 2b, now entering a broad Phase 3 program.

Elecoglipron is a non-peptide GLP-1 receptor agonist licensed from Eccogene. 6% on placebo, published in The Lancet and presented at ADA 2026.

Mechanism: Small-molecule agonism of the GLP-1 receptor taken orally once a day.

Regulatory history: Investigational; Phase 3 announced 2026

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Elecoglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Elecoglipron in other countries

Frequently asked questions

Is Elecoglipron legal in Australia?

No. Elecoglipron is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Elecoglipron in Australia?

No approved product exists to buy. In Australia Elecoglipron is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Elecoglipron TGA approved?

No. In Australia Elecoglipron is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational; Phase 3 announced 2026. Evidence level: Moderate.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Elecoglipron live on its compound profile.

Elecoglipron profile

This page is general information about the regulatory status of Elecoglipron in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.